PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.00%
Negative revenue growth while ECL.AX stands at 40.60%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-57.72%
Negative gross profit growth while ECL.AX is at 44.59%. Joel Greenblatt would examine cost competitiveness or demand decline.
-544.67%
Negative EBIT growth while ECL.AX is at 39.19%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-544.67%
Negative operating income growth while ECL.AX is at 39.19%. Joel Greenblatt would press for urgent turnaround measures.
487.94%
Net income growth of 487.94% while ECL.AX is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
234.62%
EPS growth of 234.62% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
280.00%
Diluted EPS growth of 280.00% while ECL.AX is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
74.90%
Share count expansion well above ECL.AX's 0.57%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
58.90%
Diluted share count expanding well above ECL.AX's 0.57%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative OCF growth while ECL.AX is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-3736.36%
Negative FCF growth while ECL.AX is at 309.43%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
31.79%
10Y revenue/share CAGR under 50% of ECL.AX's 327.61%. Michael Burry would suspect a lasting competitive disadvantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.00%
10Y OCF/share CAGR under 50% of ECL.AX's 699.38%. Michael Burry would worry about a persistent underperformance in cash creation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
216.80%
Positive 10Y CAGR while ECL.AX is negative. John Neff might see a substantial advantage in bottom-line trajectory.
No Data
No Data available this quarter, please select a different quarter.
137.30%
Positive short-term CAGR while ECL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Our R&D shrinks while ECL.AX invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-77.11%
We cut SG&A while ECL.AX invests at 47.98%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.